Evidence map›Paper›PMID 33115806›Full record

ArticleCancer research2020

Chromatin Looping Shapes KLF5-Dependent Transcriptional Programs in Human Epithelial Cancers.

Yanli Liu, Bingqian Guo, Estrella Aguilera-Jimenez, Vivian S Chu, Jin Zhou, Zhong Wu, Joshua M Francis, Xiaojun Yang, Peter S Choi, Swneke D Bailey and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Epigenetics-targeted drugs: current paradigms and future challenges.Signal transduction and targeted therapy · 2024
    Review
  11. Article
  12. Article
  13. Amplification ofJCO precision oncology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Yanli LiuDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Bingqian GuoDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
Estrella Aguilera-JimenezDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.ORCID 0000-0002-4160-2855
Vivian S ChuCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Jin ZhouDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Zhong WuDepartment of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
Joshua M FrancisRepertoire Immune Medicine, Boston, Massachusetts.
Xiaojun YangCollege of Animal Science and Technology, Northwest Agriculture and Forestry University, Yangling, ShanXi, China.
Peter S ChoiDepartment of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Swneke D BaileyCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada. xiaoyang.zhang@hci.utah.edu swneke.bailey@mcgill.ca.
Xiaoyang ZhangDepartment of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah. xiaoyang.zhang@hci.utah.edu swneke.bailey@mcgill.ca.
Huntsman Cancer Institute · USDana-Farber Cancer Institute · USMcGill University Health Centre · CAAgriculture and Forestry University · NPImmunetics (United States) · USUniversity of Pennsylvania · US

Funding

Investigating the role of KLF5 genomic alterations in tumorigenesisR00CA215244 · NCI · UNIVERSITY OF UTAH · PI ZHANG, XIAOYANG · 2019 to 2021
$742k
NCI NIH HHS R00 CA215244
6 · The paper itself

Abstract

Activation of transcription factors is a key driver event in cancer. We and others have recently reported that the Krüppel-like transcription factor KLF5 is activated in multiple epithelial cancer types including squamous cancer and gastrointestinal adenocarcinoma, yet the functional consequences and the underlying mechanisms of this activation remain largely unknown. Here we demonstrate that activation of KLF5 results in strongly selective KLF5 dependency for these cancer types. KLF5 bound lineage-specific regulatory elements and activated gene expression programs essential to cancer cells. HiChIP analysis revealed that multiple distal KLF5 binding events cluster and synergize to activate individual target genes. Immunoprecipitation-mass spectrometry assays showed that KLF5 interacts with other transcription factors such as TP63 and YAP1, as well as the CBP/EP300 acetyltransferase complex. Furthermore, KLF5 guided the CBP/EP300 complex to increase acetylation of H3K27, which in turn enhanced recruitment of the bromodomain protein BRD4 to chromatin. The 3D chromatin architecture aggregated KLF5-dependent BRD4 binding to activate polymerase II elongation at KLF5 target genes, which conferred a transcriptional vulnerability to proteolysis-targeting chimera-induced degradation of BRD4. Our study demonstrates that KLF5 plays an essential role in multiple epithelial cancers by activating cancer-related genes through 3D chromatin loops, providing an evidence-based rationale for targeting the KLF5 pathway. SIGNIFICANCE: An integrative 3D genomics methodology delineates mechanisms underlying the function of KLF5 in multiple epithelial cancers and suggests potential strategies to target cancers with aberrantly activated KLF5.

Indexed as

Cell LineageCell Line, TumorCell ProliferationChromatinCRISPR-Cas SystemsEpithelial CellsGene ExpressionGene Expression Regulation, NeoplasticHumansKruppel-Like Transcription FactorsNeoplasms, Glandular and EpithelialPhenotypePromoter Regions, GeneticProtein BindingTranscription, GeneticChromatinKLF5 protein, humanKruppel-Like Transcription Factors

Identifiers

PMID33115806
PMCPMC7787512
OpenAlexW3096247510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.